NCCN Meeting on Blood Cancers Empowers Interprofessional Care Teams

PLYMOUTH MEETING, Pa., Oct. 4, 2021 /CNW/ -- The National Comprehensive Cancer Network^® (NCCN^®) will conduct a three-day, live virtual congress October 14-16, 2021 addressing the latest in therapeutic advances, updates to the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines^®), and treatment debates across the broad spectrum of blood cancers. Incorporating interactive polling and moderator-facilitated Q&A sessions, the NCCN Virtual Congress: Hematologic Malignancies™ is designed to meet the needs of the full interprofessional care team, including physicians, nurse practitioners, nurses, physician assistants, pharmacists, and other health care professionals who manage the care of patients with hematologic malignancies.

Additionally, NCCN will host the NCCN Virtual Nursing Forum: Advancing Oncology Nursing in Hematologic Malignancies™, on Friday, October 8, 2021 to provide nurses with comprehensive and clinically relevant information to optimize care for patients with blood cancers.

"In response to the ongoing COVID-19 pandemic, this year's congress will again be presented in a virtual format through both live and on-demand webcasts," said Andrew D. Zelenetz, MD, PhD, Memorial Sloan Kettering Cancer Center (MSK) and congress co-chair. "While we prefer face-to-face interactions, we are gratified that we can still deliver a valuable interactive experience that helps maintain the high quality of patient care across the country—and the globe." 

"The NCCN Annual Congress for hematologic malignancies provides a platform for leading experts to share and debate the latest evidence and practice recommendations for patient management," said event co-chair Ranjana H. Advani, MD, Stanford Cancer Institute. "Our hope is that clinicians who attend will be better equipped to put novel therapies and treatment guidelines into practice."

Interactive Virtual Conference
The NCCN 2021 Virtual Congress: Hematologic Malignancies™ will focus on the current standards of hematologic oncology care as well as key updates to the NCCN Guidelines^®. Presentations will include treatment updates and patient case studies on:

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
• Chronic Myeloid Leukemia
• Diffuse Large B-Cell Lymphoma
• Follicular Lymphoma
• Histiocytic Neoplasms
• Hodgkin Lymphoma
• Mantle Cell Lymphoma
• Marginal Zone Lymphomas
• Monoclonal Gammopathy of Clinical Significance
• Multiple Myeloma
• Myeloproliferative Neoplasms
• Non-Hodgkin Lymphomas
• Plasma Cell Neoplasms
• Peripheral T-Cell Lymphomas
• Systemic Light Chain Amyloidosis
• Waldenström Macroglobulinemia

The congress' virtual format will offer opportunities for participants to engage with faculty in real time, to visit an online exhibition hall, and to network with colleagues in breakout rooms. For 60 days following the event, registrants will also be able to access all of the recorded presentations, allowing time to review sessions they may have missed or revisit sessions important to their practice. NCCN expects more than 500 healthcare professionals to participate.

"We are gratified by the broad range of oncology professionals who attend this congress," said Robert W. Carlson, MD, Chief Executive Officer, NCCN. "Last year, attendance was 29% physicians, 30% nurses, 11% pharmacists, and 30% other healthcare professionals; 69% of the respondents to our survey reported that they work as part of an interprofessional health care team. This mix makes for dynamic practice discussions based on multiple informed perspectives that are critical to improving patient outcomes."

Join the conversation online with the hashtag #NCCNhem21.

About the National Comprehensive Cancer Network
The National Comprehensive Cancer Network^® (NCCN^®) is a not-for-profit alliance of leading cancer centers devoted to patient care, research, and education. NCCN is dedicated to improving and facilitating quality, effective, efficient, and accessible cancer care so patients can live better lives. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines^®) provide transparent, evidence-based, expert consensus recommendations for cancer treatment, prevention, and supportive services; they are the recognized standard for clinical direction and policy in cancer management and the most thorough and frequently-updated clinical practice guidelines available in any area of medicine. The NCCN Guidelines for Patients^® provide expert cancer treatment information to inform and empower patients and caregivers, through support from the NCCN Foundation^®. NCCN also advances continuing education, global initiatives, policy, and research collaboration and publication in oncology. Visit NCCN.org for more information and follow NCCN on Facebook @NCCNorg, Instagram @NCCNorg, and Twitter @NCCN.

Media Contact:
Rachel Darwin
267-622-6624
[email protected]

SOURCE National Comprehensive Cancer Network

Related Links

www.nccn.org